Sumatriptan (Migratan (100 mg)) is a selective serotonin receptor agonist, prescribed for the acute treatment of migraine attacks with or without aura in adults (severe, throbbing headaches that ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE:RDY) today announced that it has launched the authorized generic version of GlaxoSmithKline's Imitrex® (sumatriptan succinate) tablets ...

Triptans are effective medicines used to treat migraine headaches. They significantly reduce pain within two hours for most people. Complete relief is less common, but the likelihood may be greater if ...

Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine --Migraine Sufferers ...

MUMBAI, Feb 1 (Reuters) - Drug maker Aurobindo Pharma Ltd said on Friday it received tentative approval from the U.S. Food and Drug Administration for its sumatriptan succinate tablets, used to treat ...

1 Pediatric Headache Fellow, Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA. 2 ...

The Centers for Disease Control and Prevention estimates there are 37 million migraine sufferers in the U.S., and that roughly 13 million prescriptions are written annually for triptan medicines to ...

Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched the authorized generic version of GlaxoSmithKline’s Imitrex® (sumatriptan succinate) tablets 25mg, 50mg, and 100mg in the ...